- Home
- ANY vs COCH Comparison
ANY vs COCH Comparison
Compare ANY & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ANY | COCH |
|---|---|---|
| Founded | N/A | 1995 |
| Country | United States | United States |
| Employees | N/A | 47 |
| Industry | Finance: Consumer Services | Blank Checks |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1M | 53.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANY | COCH |
|---|---|---|
| Price | $1.73 | $0.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $30.00 | $6.00 |
| AVG Volume (30 Days) | 333.2K | ★ 783.4K |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,181,000.00 | N/A |
| Revenue This Year | $15.62 | $1.58 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.16 | $0.36 |
| 52 Week High | $6.20 | $1.89 |
Technical Indicators
Market Signals| Indicator | ANY | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 35.64 | 49.31 |
| Support Level | $1.60 | $0.64 |
| Resistance Level | $1.92 | $0.74 |
| Average True Range (ATR) | 0.23 | 0.08 |
| MACD | -0.11 | -0.00 |
| Stochastic Oscillator | 9.78 | 32.50 |
Price Performance
Historical ComparisonAbout ANY Sphere 3D Corp.
Sphere 3D Corp is engaged in the Bitcoin mining business. The company has established an enterprise-scale mining operation through the procurement of mining equipment and partnering with experienced service providers. It generates revenue from mining and selling Bitcoin.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.